HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...

Heartflow has pumped up its IPO ambitions, raising its proposal into the vicinity of $300 million. | After first pricing its ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Backed by Bain Capital, the health technology startup creates 3D models of people’s hearts to help diagnose diseases. Here’s ...

Heartflow on Wednesday said it now plans to sell nearly 16.7 million shares at between $17 and $18 apiece in the IPO, compared with prior plans to offer 12.5 million shares at between $15 and $17 each ...

Heartflow said it would have about 79.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $1.27 billion at the $16-a-share ...

Like waves crashing on the beach, med-tech IPOs keep on coming. Heartflow Inc. set terms for its IPO on Aug. 1, offering 12.5 ...

Now HeartFlow has developed a new technology called Planner which takes things a step further by allowing doctors to virtually model surgery in real-time. This means that cardiologists can work ...

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized initial public offering in the United States, indicating robust investor ...